Poster Abstract Session:
173. Viral Treatment and Prevention
Friday, October 6, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

CHIKUNGUNYA: A Mortality Report
Atul Gogia, MRCP(UK); Sairam B, MBBS; Atul Kakar, DNB
Correlation between Cytomegalovirus (CMV) Breakthrough in High Risk Solid Organ Transplant Recipient and Valganciclovir Dose Modification
Juan Lemos-Ramirez, MD; Odaliz Abreu-Lanfranco, MD; Ramon Del Busto, MD; Mayur Ramesh, M.D.; Jonathan Williams, MD; Pallavi Bhargava, MD; Eloy Ordaya, MD; George Alangaden, MD, FIDSA
Significant Neutralizing Antibody and Cytolytic T Cell Responses to GEN-003, a Herpes Simplex Virus Immunotherapy, in a Phase 2b Study
Lisa K. McNeil, PhD; Amy Baccari, BS; Veronica Clemens, BS; David Dominguez, BS; Tyler Fenske, BS; Thomas Oliphant, MS, PhD; James Perry, BA; Nicolle Siddall, BS; Jin Yuan, PhD; Thomas Heineman, MD, PhD; Seth Hetherington, MD; Jessica B. Flechtner, PhD
A Phase 2a Study to Evaluate the Safety of MEDI8852 in Outpatient Adults with Acute, Uncomplicated Influenza A
Omar Ali, PhD; Therese Takas, BS; Andrew C. Nyborg, PhD; Kathryn M. Jensen, MS; Filip Dubovsky, MD; Raburn Mallory, MD
Single Dose IV Peramivir Treatment in Pediatric Influenza: Lack of Development of Influenza Virus Variants with Reduced Susceptibility to Peramivir
Marie-Ève Hamelin, PhD; Yacine Abed, PhD; Julie Carbonneau, MSc; Rienk Jeeninga, PhD; Saskia Smits, PhD; Smail Kulenovic, BSc; Katyna Borroto-Esoda, PhD; Ray Taylor, MBA; Phil Collis, PhD; Guy Boivin, MD
2016-2017 Seasonal Influenza Vaccine Availability at Urgent Care Centers in the state of Arizona, USA
Norman Beatty, MD; Kelly Hager, MPH; Kyle Mckeown, MPH; Francisco Mora, MD; Kathryn Matthias, PharmD; David Nix, PharmD; Mayar Al Mohajer, MD, MBA, CAQ, FACP
Antiviral Activity of Peptide Nucleic Acid against Human Parechovirus Type 3
Taketo Otsuka, MD, PhD; Ryohei Izumita, MD; Kanako Watanabe, PhD; Akihiko Saitoh, MD, PhD
Preventing Respiratory Viruses in the Neonatal ICU
Maria Messina, RN; Jessica Shui, MD; Philip Maykowski, MPH; Tine Leone, MD; Lisa Saiman, MD, MPH
  • 1661_IDWeek Poster.pdf (668.8 kB)
  • Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients
    Farnaz Foolad, PharmD; Samuel L. Aitken, PharmD; Amrita Prayag, MD; Shashank S. Ghantoji, MD, PhD, MPH; Ella Ariza-Heredia, MD; Dimpy P. Shah, MD, MSPH; Roy Chemaly, MD, MPH

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.